86 related articles for article (PubMed ID: 21304898)
1. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model.
Siegers GM; Felizardo TC; Mathieson AM; Kosaka Y; Wang XH; Medin JA; Keating A
PLoS One; 2011 Feb; 6(2):e16700. PubMed ID: 21304898
[TBL] [Abstract][Full Text] [Related]
2. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
Schmidt-Wolf IG; Negrin RS; Kiem HP; Blume KG; Weissman IL
J Exp Med; 1991 Jul; 174(1):139-49. PubMed ID: 1711560
[TBL] [Abstract][Full Text] [Related]
3. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
[TBL] [Abstract][Full Text] [Related]
4. Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI.
Siegers GM; Ribot EJ; Keating A; Foster PJ
Cancer Immunol Immunother; 2013 Mar; 62(3):571-83. PubMed ID: 23100099
[TBL] [Abstract][Full Text] [Related]
5. Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.
Du SH; Li Z; Chen C; Tan WK; Chi Z; Kwang TW; Xu XH; Wang S
PLoS One; 2016; 11(9):e0161820. PubMed ID: 27598655
[TBL] [Abstract][Full Text] [Related]
6.
Wu D; Wu P; Wu X; Ye J; Wang Z; Zhao S; Ni C; Hu G; Xu J; Han Y; Zhang T; Qiu F; Yan J; Huang J
Oncoimmunology; 2015 Mar; 4(3):e992749. PubMed ID: 25949914
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the immune response of human cord-blood derived gamma/delta T cells to stimulation with aminobisphosphonate compounds.
Placido R; Auricchio G; Gabriele I; Galli E; Brunetti E; Colizzi V; Battistini L; Mancino G
Int J Immunopathol Pharmacol; 2011; 24(1):101-10. PubMed ID: 21496392
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells.
Le Floch AC; Rouvière MS; Salem N; Ben Amara A; Orlanducci F; Vey N; Gorvel L; Chretien AS; Olive D
Cells; 2023 Jun; 12(13):. PubMed ID: 37443727
[TBL] [Abstract][Full Text] [Related]
9. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.
Knight A; Piskacek M; Jurajda M; Prochazkova J; Racil Z; Zackova D; Mayer J
Cancer Immunol Immunother; 2023 May; 72(5):1209-1224. PubMed ID: 36376516
[TBL] [Abstract][Full Text] [Related]
10. Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy.
Allegra A; Casciaro M; Lo Presti E; Musolino C; Gangemi S
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740879
[TBL] [Abstract][Full Text] [Related]
11. Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.
de Araújo ND; Gama FM; de Souza Barros M; Ribeiro TLP; Alves FS; Xabregas LA; Tarragô AM; Malheiro A; Costa AG
J Immunol Res; 2021; 2021():6633824. PubMed ID: 33506055
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
13. Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells.
Bhat J; Dubin S; Dananberg A; Quabius ES; Fritsch J; Dowds CM; Saxena A; Chitadze G; Lettau M; Kabelitz D
Front Immunol; 2019; 10():569. PubMed ID: 30972064
[TBL] [Abstract][Full Text] [Related]
14. Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.
Hoeres T; Smetak M; Pretscher D; Wilhelm M
Front Immunol; 2018; 9():800. PubMed ID: 29725332
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.
Jin Z; Luo Q; Lu S; Wang X; He Z; Lai J; Chen S; Yang L; Wu X; Li Y
J Hematol Oncol; 2016 Nov; 9(1):126. PubMed ID: 27863523
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.
McCarthy NE; Hedin CR; Sanders TJ; Amon P; Hoti I; Ayada I; Baji V; Giles EM; Wildemann M; Bashir Z; Whelan K; Sanderson I; Lindsay JO; Stagg AJ
J Clin Invest; 2015 Aug; 125(8):3215-25. PubMed ID: 26168223
[TBL] [Abstract][Full Text] [Related]
17. The Jekyll and Hyde story of IL17-Producing γδT Cells.
Patil RS; Bhat SA; Dar AA; Chiplunkar SV
Front Immunol; 2015; 6():37. PubMed ID: 25699053
[TBL] [Abstract][Full Text] [Related]
18. γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes.
Airoldi I; Bertaina A; Prigione I; Zorzoli A; Pagliara D; Cocco C; Meazza R; Loiacono F; Lucarelli B; Bernardo ME; Barbarito G; Pende D; Moretta A; Pistoia V; Moretta L; Locatelli F
Blood; 2015 Apr; 125(15):2349-58. PubMed ID: 25612623
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis.
Laurent AJ; Bindslev N; Johansson B; Berg L
PLoS One; 2014; 9(8):e103683. PubMed ID: 25090614
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
